Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Cryogenic Solutions Inc. (CYGS) -- Ignore unavailable to you. Want to Upgrade?

To: Graham Marshman who wrote (2842)	8/14/1998 9:50:00 PM
From: Nancy McKinney	Read Replies (1) \| Respond to of 4028

To All, Here are some interesting things I have been learning lately. The MONEY mag article says that the biotech boom is in Stage 1, and that the fuel to the boom is the study of how genes work. (Does anyone here remember when PC investing was in Stage 1? It didn't take long to make a lot of savvy investors nice profits.) Knowledge about genes (genomics) "is doubling every 12 to 24 months." The big pharma co's are looking at the gene research that decodes the genes. They want to spot genetic diseases AND improve agriculture, and so they are making alliances with these research co.'because this is where the future of medicine and agriculture is! (remember the shrimp issue?) DNA is the "software" that programs your health. We have 100,000 genes made up of DNA. Now, If CYGS has the technol. to get the DNA to cells to "reprogram them with health" (my interpretation), then they SEEM to be in that loop somewhere, but I need a scientist to tell me where. We might get a scientist on this thread if we don't take up so much time posting like looney tunes. People, this is your money here! How about a little research? Nancy

To: Graham Marshman who wrote (2842)	8/15/1998 12:38:00 AM
From: Jeffrey S. Mitchell	Read Replies (3) \| Respond to of 4028

Graham, good to see someone sticking to the science here. I have a few questions: 1. What other cell lines will the vector work on? I suspect they should at least already have nailed down Cos-7, but what is the timetable for the others? 2. What type of applications are we talking about here? a) Anti-cancer, b) telomerase, c) antisense, d) all three 3. Has any patent yet been granted? Anyone can file a patent. And even if CYGS has excellent technology, without a patent being granted they run the risk of patent infringement. What they are doing is a very competitive thing, so without a patent, they have no leg to stand on, and as CYGS is betting the farm on this, no CYGS. 4. How close are they to any sort of clinical application? 5. When do they expect Dr. Conrad to finally publish on his research, and in what medical journal do they realistically hope to be accepted into? If CYGS truly does have something that will "rock the medical world", then I expect them to say Nature or Scientific American. At the very least, if the technology is "decent", I expect Cell. - Jeff